Rewrite the rules
How will Brexit impact medical device regulation? Will this add barriers to approval, investment and ultimately patient access? Can new regulations create more opportunities?
FACILITATED BY
JAMES FRY | Partner and Head of Life Sciences |Mills & Reeve
PANELLISTS INCLUDE
TIM ANDREWS | Chief Operating Officer and Commercial Director | ORCHA
KAREN TAYLOR | Director, Deloitte Centre for Health Solutions | Clients & Industries | Deloitte LLP
MICHAEL KIPPING | Innovation Lead – Biomedical Catalyst, Health Sector Team | Innovate UK
PAOLO GUERRA | MedTech Lead | ProductLife Group
ALEJANDRO (ALEX) FRANGI | Diamond Jubilee Chair in Computational Medicine | University of Leeds